ROS-mediated iron overload injures the hematopoiesis of bone marrow by damaging hematopoietic stem/progenitor cells in mice

被引:112
作者
Chai, Xiao [1 ,4 ]
Li, Deguan [2 ,3 ]
Cao, Xiaoli [1 ]
Zhang, Yuchen [1 ]
Mu, Juan [1 ]
Lu, Wenyi [1 ]
Xiao, Xia [1 ]
Li, Chengcheng [2 ,3 ]
Meng, Juanxia [1 ]
Chen, Jie [1 ]
Li, Qing [1 ]
Wang, Jishi [4 ]
Meng, Aimin [2 ,3 ]
Zhao, Mingfeng [1 ]
机构
[1] Tianjin First Cent Hosp, Dept Hematol, Tianjin 300192, Peoples R China
[2] Acad Med Sci, Inst Radiat Med, Tianjin Key Lab Radiat Med & Mol Nucl Med, Tianjin 300192, Peoples R China
[3] Peking Union Med Coll, Tianjin 300192, Peoples R China
[4] Affiliated Hosp Guizhou Med Univ, Dept Hematol, Guiyang 550004, Peoples R China
关键词
OXIDATIVE STRESS; CHELATION-THERAPY; PREMATURE SENESCENCE; IONIZING-RADIATION; STEM-CELL; IMPROVEMENT; PROGENITORS; INDUCTION; DISEASE;
D O I
10.1038/srep10181
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Iron overload, caused by hereditary hemochromatosis or repeated blood transfusions in some diseases, such as beta thalassemia, bone marrow failure and myelodysplastic syndrome, can significantly induce injured bone marrow (BM) function as well as parenchyma organ dysfunctions. However, the effect of iron overload and its mechanism remain elusive. In this study, we investigated the effects of iron overload on the hematopoietic stem and progenitor cells (HSPCs) from a mouse model. Our results showed that iron overload markedly decreased the ratio and clonogenic function of murine HSPCs by the elevation of reactive oxygen species (ROS). This finding is supported by the results of NAC or DFX treatment, which reduced ROS level by inhibiting NOX4 and p38MAPK and improved the long-term and multi-lineage engrafment of iron overload HSCs after transplantation. Therefore, all of these data demonstrate that iron overload injures the hematopoiesis of BM by enhancing ROS through NOX4 and p38MAPK. This will be helpful for the treatment of iron overload in patients with hematopoietic dysfunction.
引用
收藏
页数:11
相关论文
共 32 条
[1]   Medical progress: Disorders of iron metabolism [J].
Andrews, NC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (26) :1986-1995
[2]   The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology [J].
Bedard, Karen ;
Krause, Karl-Heinz .
PHYSIOLOGICAL REVIEWS, 2007, 87 (01) :245-313
[3]   When should iron chelation therapy be considered in patients with myelodysplasia and other bone marrow failure syndromes with iron overload? [J].
Bird, R. J. ;
Kenealy, M. ;
Forsyth, C. ;
Wellwood, J. ;
Leahy, M. F. ;
Seymour, J. F. ;
To, L. B. .
INTERNAL MEDICINE JOURNAL, 2012, 42 (04) :450-455
[4]   Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders [J].
Camaschella, C .
BLOOD, 2005, 106 (12) :3710-3717
[5]   Longitudinal analysis of heart and liver iron in thalassemia major patients according to chelation treatment [J].
Danjou, F. ;
Origa, R. ;
Anni, F. ;
Saba, L. ;
Cossa, S. ;
Podda, G. ;
Galanello, R. .
BLOOD CELLS MOLECULES AND DISEASES, 2013, 51 (03) :142-145
[6]   Iron overload impairs proliferation of erythroid progenitors cells (BFU-E) from patients with myelodysplastic syndromes [J].
Hartmann, Julia ;
Braulke, Friederike ;
Sinzig, Ursula ;
Wulf, Gerald ;
Maas, Jens Holger ;
Konietschke, Frank ;
Haase, Detlef .
LEUKEMIA RESEARCH, 2013, 37 (03) :327-332
[7]   Advances in iron chelation: an update [J].
Heli, Hossein ;
Mirtorabi, Siamak ;
Karimian, Khashayar .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2011, 21 (06) :819-856
[8]   Extramedullary hematopoiesis is dysregulated in histamine-free histidine decarboxylase knockout (HDC-/-) mice [J].
Horvath, Zsuzsanna ;
Pallinger, Eva ;
Horvath, Gyozo ;
Jelinek, Ivett ;
Veszely, Gizella ;
Furesz, Jozsef ;
Falus, Andras ;
Buzas, Edit I. .
INFLAMMATION RESEARCH, 2010, 59 (06) :429-436
[9]   AKT1 and AKT2 maintain hematopoietic stem cell function by regulating reactive oxygen species [J].
Juntilla, Marisa M. ;
Patil, Vineet D. ;
Calamito, Marco ;
Joshi, Rohan P. ;
Birnbaum, Morris J. ;
Koretzky, Gary A. .
BLOOD, 2010, 115 (20) :4030-4038
[10]   Improvement of iron-mediated oxidative DNA damage in patients with transfusion-dependent myelodysplastic syndrome by treatment with deferasirox [J].
Kikuchi, Shohei ;
Kobune, Masayoshi ;
Iyama, Satoshi ;
Sato, Tsutomu ;
Murase, Kazuyuki ;
Kawano, Yutaka ;
Takada, Kohichi ;
Ono, Kaoru ;
Kaneko, Yumiko ;
Miyanishi, Koji ;
Sato, Yasushi ;
Hayashi, Tsuyoshi ;
Takimoto, Rishu ;
Kato, Junji .
FREE RADICAL BIOLOGY AND MEDICINE, 2012, 53 (04) :643-648